- active not recruitingPHASE2, PHASE3
Open Label Extension to Assess the Long-Term Safety and Tolerability of ZYN002 in Children and Adolescents With FXS
United States · Australia · New Zealand - authorisedTherapeutic exploratory (Phase II)
Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of MRM-3379 in Male Participants with Fragile X Syndrome
This study is testing a new medicine, MRM-3379, for men with Fragile X Syndrome. Researchers want to see if it's safe and if it helps with thinking and learning abilities. Some men will also receive a dummy pill.
Spain - ongoing, recruitingHuman Pharmacology (Phase I)- First administration to humans
Safety and tolerability of CTH120, first-in-human phase I study encompassing three parts: Single and Multiple Ascending doses and potential Food Interaction
Spain - ongoing, recruitingHuman Pharmacology (Phase I)- First administration to humans
A study to learn how safe KER-0193 is, the activity of KER-0193 in the body over a period of time, and the effect of KER-0193 to the body in adult healthy people taking single and multiple doses by the mouth that are increased a little at a time
Belgium